ABHA's Scan and Share Service Facilitates 3 Crore OPD Registrations NationwideKongposh Publications – Historic Roots - 2
COVID-19: Myth vs. Facts
Some media reports are suggesting that Union Ministry of Health & Family Welfare has in a meeting with the Election Commission of India (ECI) yesterday suggested that the “COVID situation in the country is nothing to be worried about” and “there is no cause of alarm or concern in the view of very few cases […]
WHO Director-General's opening remarks at the media briefing on COVID-19
Lists Video Link Audio Link Happy New Year! The dawn of a new year offers an opportunity to renew our collective response to a shared threat. I hope global leaders who have shown such resolve in protecting their own populations will extend that resolve to make sure that the whole world is safe and protected. […]
Dr. Mansukh Mandaviya reviews Public Health Preparedness to COVID19 and National COVID19 Vaccination Progress with States/UT
Dr. Mansukh Mandaviya, Union Minister of Health and Family Welfare today virtually interacted with State Health Ministers and Principal Secretaries/ Additional Chief Secretaries of States/UTs to review the Public Health Preparedness to COVID19 and progress of National COVID19 vaccination campaign. The meeting was held in view of the rising cases of the Omicron variant and […]
Efforts to boost manufacturing capacity in pharmaceutical sector
With a view to attain self-reliance and reduce import dependence in critical APIs, a scheme called “Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) In India” was approved by the Government. The total outlay of the scheme is Rs.6,940 […]
WHO lists 10th COVID-19 vaccine for emergency use: Nuvaxovid
The World Health Organization issued an emergency use listing (EUL) for Nuvaxovid™, following its assessment and approval by the European Medicines Agency (EMA) earlier today. The new vaccine was developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI), and is the originator product for the Covovax™ vaccine that received WHO emergency use listing […]
Steps taken to Ensure Access to Testing, Treatment and Vaccines
Under National COVID-19 Vaccination Programme, COVID-19 vaccine is available free of cost for all citizens aged 18 years and above irrespective of their socio-economic status at all Government COVID-19 Vaccination Centres (CVCs). There is provision to facilitate vaccination of persons without prescribed identity cards such as migrants, seers, nomads, refugees, destitute, homeless people, beggars etc.through […]
Democratic Republic of the Congo declares Ebola outbreak over
The Ebola outbreak that erupted in the Democratic Republic of the Congo’s North Kivu Province in October – the second in 2021 – was today declared over, the national health authorities announced after no new cases were reported at the end of a 42-day countdown, or two incubation periods after the last confirmed case was […]
Emragoed Press Release and News Package: Childhood Cancer Medicines
The World Health Organization and St. Jude Children’s Research Hospital today announced plans to establish a platform that will dramatically increase access to childhood cancer medicines around the world. The Global Platform for Access to Childhood Cancer Medicines, the first of its kind, will provide an uninterrupted supply of quality-assured childhood cancer medicines to low-and […]
Update on National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS)
Under the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) launched in 2010 as part of National Health Mission (NHM), the Union Ministry of Health & Family Welfare provides technical and financial support to the States/UTs based on the proposals received from the States/UTs and subject to the resource […]
Update on COVID-19 Vaccine Manufacturing Capacity
ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) (COVISHIELD) is manufactured by M/s Serum Institute of India Pvt., Ltd., Pune, while the Whole Virion Inactivated Corona Virus Vaccine (COVAXIN) is manufactured by M/s Bharat Biotech International Limited, Hyderabad. As communicated by the M/s Serum Institute of India, the current monthly vaccine production capacity of Covishield is […]
1 121 122 123 124 125 156
©2025 Life Science World. All rights reserved
crosschevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram